[1] Haddad A, Tyan P, Radwan A, et al. β- Thalassemia Inter?
media: A Bird's- Eye View [J]. Turk J Haematol, 2014,31
(1) :5-16.
[2] 黄海龙,徐两蒲,林娜,等.福建省β-地中海贫血基因突变类型分
析[J].中国地方病学杂志,2012,31 (2) :177-181.
[3] Koren A, Profeta L, Zalman L, et al. Prevention of β Thalas?
semia in Northern Israel - a Cost- Benefit Analysis [J].
Mediterr J Hematol Infect Dis, 2014,6 (1) :e2014012.
[4] 徐湘民.地中海贫血预防控制操作指南[M].北京:人民军医
出版社,2011.
[5] Vinciguerra M, Passarello C, Leto F, et al. Identification of
three new nucleotide substitutions in the β-globin gene: labora?
toristic approach and impact on genetic counselling for betathalassaemia
[J]. Eur J Haematol, 2014,92 (5) :444-449.
[6] Usman M, Moinuddin M, Ghani R. Molecular genetics of be?
ta- thalassaemia syndrome in Pakistan [J]. East Mediterr
Health J, 2010,16 (9) :972-976.
[7] Aydinok Y. Thalassemia [J].Hematology, 2012,17 (Suppl
1) :S28-31.
[8] Xu LH, Fang JP, Weng WJ, et al. Autoimmune hemolytic
anemia in patients with β-thalassemia major [J].Pediatr He?
matol Oncol, 2012,29 (3) :235-240.
[9] Kosaryan M, Mahdavi MR, Roshan P, et al. Prevalence of al?
loimmunisation in patients with beta thalassaemia major [J].
Blood Transfus, 2012,10 (3) :396-397.
[10] 禹兰梅.血常规在缺铁性贫血和地中海贫血中的鉴别诊断价值
[J].中外医学研究,2014,12 (3) :76-77.
[11] Blattner A, Brunner- Agten S, Ludin K, et al. Detection of
germline rearrangements in patients with α- and β-thalassemia
using high resolution array CGH [J]. Blood Cells Mol Dis,
2013,51 (1) :39-47.
[12] 廖灿,李茹,魏明,等.高分辨率熔解曲线分析技术在快速产前诊
断β-地中海贫血中的应用[J]. 中华妇产科杂志,2012,47
(9) :692-694.
[13] Voskaridou E, Balassopoulou A, Boutou E, et al. Pregnancy
in beta- Thalassemia Intermedia: 20- year Experience of a
Greek Thalassemia Centre [J]. Eur J Haematol, 2014,
[Epub ahead of print] .
[14] Pennell DJ, Porter JB, Piga A, et al. A 1- year randomized
controlled trial of deferasirox vs deferoxamine for myocardial
iron removal in β- thalassemia major (CORDELIA)[J].
Blood, 2014,123 (10) :1447-1454.
[15] Veríssimo MP, Loggetto SR, Fabron Junior A, et al. Brazil?
ian Thalassemia Association protocol for iron chelation therapy
in patients under regular transfusion [J]. Rev Bras Hematol
Hemoter, 2013,35 (6) :428-434.
[16] Chakrabarty P, Rudra S, Hossain MA, et al. Iron chelation
therapy and thalassemia - an overview [J]. Mymensingh
Med J, 2011,20 (3) :513-519.
[17] Trad O, Hamdan MA, Jamil A, et al. Reversal of iron- in?
duced dilated cardiomyopathy during therapy with deferasirox
in beta- thalassemia [J]. Pediatr Blood Cancer, 2009,52
(3) :426-428.
[18] Tafrali C, Paizi A, Borg J, et al. Genomic variation in the
MAP3K5 gene is associated with β-thalassemia disease severi?
ty and hydroxyurea treatment efficacy [J].Pharmacogenom?
ics, 2013,14 (5) :469-483.
[19] Breda L, Rivella S, Zuccato C, et al. Combining gene therapy
and fetal hemoglobin induction for treatment of β- thalassemia
[J]. Expert Rev Hematol, 2013,6 (3) :255-264.
[20] Olivieri NF, Saunthararajah Y, Thayalasuthan V, et al. A pi?
lot study of subcutaneous decitabine in β- thalassemia interme?
dia [J].Blood, 2011,118 (10) :2708-2711.
[21] Hebbel RP, Vercellotti GM, Pace BS, et al. The HDAC in?
hibitors trichostatin A and suberoylanilide hydroxamic acid ex?
hibit multiple modalities of benefit for the vascular pathobiolo?
gy of sickle transgenic mice [J]. Blood, 2010,115 (12) :
2483-2490.
[22] Andreani M, Testi M, Gaziev J, et al. Quantitatively different
red cell/nucleated cell chimerism in patients with long- term,
persistent hematopoietic mixed chimerism after bone marrow
transplantation for thalassemia major or sickle cell disease [J].
Haematologica, 2011,96 (1) :128-133.
[23] Yannaki E, Karponi G, Zervou F, et al. Hematopoietic stemcell mobilization for gene therapy: superior mobilization by the
combination of granulocyte- colony stimulating factor plus
plerixafor in patients with β- thalassemia major [J]. Hum
Gene Ther, 2013,24 (10) :852-860.
[24] Drakopoulou E, Papanikolaou E, Georgomanoli M, et al. To?
wards more successful gene therapy clinical trials for β- thalas?
semia [J].Curr Mol Med, 2013,13 (8) :1314-1330.
[25] Zuccato C, Breda L, Salvatori F, et al. A combined approach
for β- thalassemia based on gene therapy- mediated adult he?
moglobin (HbA) production and fetal hemoglobin (HbF)
induction [J].Ann Hematol, 2012,91 (8) :1201-1213.
[26] Gaziev J, Lucarelli G. Hematopoietic stem cell transplantation
for thalassemia [J].Curr Stem Cell Res Ther, 2011,6 (2) :
162-169.
[27] 吴学东,井远方,温建芸,等.造血干细胞移植治疗地中海贫血
[J].中国组织工程研究,2012,16 (23) :4339-4348.